시장보고서
상품코드
1452818

세계의 유전자 독성 검사 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별 - 산업 예측(2024-2031년)

Global Genetic Toxicology Testing Market Size, Share, Growth Analysis, By Product(Reagents & Consumables, Assays), By Application(Pharmaceutical & Biotechnology, Food Industry) - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 유전자 독성 검사 시장 규모는 2022년 13억 1,000만 달러로 평가되었습니다. 2023년 14억 8,000만 달러에서 2031년까지 38억 4,000만 달러에 달하고, 예측 기간(2024-2031년) 동안 12.70%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다./p>

유전자 독성 검사는 제약, 생명공학 및 화학 산업에서 중요한 역할을 하고 있으며, 신약, 화학물질 및 소비자 제품의 안전성 평가의 기본 요소로 자리 잡고 있습니다. 이 단계는 인간의 건강과 환경 모두에 대한 잠재적 위험을 철저히 평가할 수 있도록 보장합니다. 규제 당국의 감시 강화, 검사 방법의 발전, 공중 보건 및 안전에 대한 관심 증가로 인해 시장의 중요성이 증가하고 있습니다. 제약 및 화학 분야의 R&D 활동 확대, 세계 보건 및 위생 규제 강화, 유전독성 물질 노출로 인한 장기적 영향 가능성에 대한 인식이 높아짐에 따라 시장 성장에 대한 기대감이 높아지고 있습니다. 전통적인 검사는 여전히 필수적이지만, in vitro 소핵 분석, in silico 모델링, 하이스루풋 스크리닝과 같은 혁신적인 기술이 이를 보완하여 보다 신속하고 정확하며 비용 효율적인 검사를 가능하게 하고 있습니다. 또한, 동물 사용을 최소화하기 위한 대체 검사법으로의 전환은 윤리적 고려 사항과 규제 요건에 부합하여 비동물 검사 모델의 채택을 촉진하고 있습니다. 유전자 독성 검사 전문 개발 위탁기관 등 시장의 주요 업체들은 다양한 검사 서비스를 제공함으로써 시장의 역동적인 상황에 기여하고 있습니다.

목차

주요 요약

  • 시장 개요
  • Wheel of Fortune

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 유전자 독성 검사 시장 : 제품별

  • 시장 개요
  • 시약 및 소모품
  • 어세이
  • 서비스

세계의 유전자 독성 검사 시장 : 용도별

  • 시장 개요
  • 제약 및 바이오테크놀러지
  • 식품 업계
  • 화장품 산업
  • 기타

세계의 유전자 독성 검사 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Covance Inc.(USA)
  • Eurofins Scientific SE(Luxembourg)
  • Charles River Laboratories International Inc.(USA)
  • SGS SA(Switzerland)
  • Merck KGaA(Germany)
  • Laboratory Corporation of America Holdings(LabCorp)(USA)
  • Thermo Fisher Scientific Inc.(USA)
  • Toxikon Corporation(USA)
  • WuXi AppTec(China)
  • Genetic Toxicology Association(GTA)(USA)
  • BioReliance Corporation(USA)
  • Intertek Group plc(UK)
  • Shanghai Medicilon Inc.(China)
  • Bio-Rad Laboratories, Inc.(USA)
  • MPI Research(USA)
  • Cell Systems Corporation(USA)
  • CeeTox Inc.(USA)
  • Gentronix Ltd.(UK)
  • LabGenius Limited(UK)
  • Molecular Toxicology Inc.(USA)
  • Ricerca Biosciences LLC(USA)
  • ATCC(American Type Culture Collection)(USA)
  • Coy Laboratory Products Inc.(USA)
  • Promega Corporation(USA)
  • Creative Bioarray(USA)
LSH 24.04.12

Global Genetic Toxicology Testing Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.84 billion by 2031, growing at a CAGR of 12.70% during the forecast period (2024-2031).

Genetic toxicology testing plays a crucial role in the pharmaceutical, biotechnology, and chemical industries, serving as a fundamental component in the safety assessment of new drugs, chemicals, and consumer products. This phase ensures a thorough evaluation of potential risks to both human health and the environment. The market's significance is on the rise due to heightened regulatory scrutiny, advancements in testing methodologies, and an increased focus on public health and safety. Factors driving its notable growth include expanding research and development activities in pharmaceutical and chemical sectors, stringent global health regulations, and a growing awareness of the potential long-term impacts of exposure to genotoxic substances. While traditional tests remain essential, innovative techniques such as in vitro micronucleus assays, in silico modeling, and high-throughput screening methods are complementing them, facilitating faster, more accurate, and cost-effective testing. Additionally, the shift towards alternative testing methods to minimize animal usage aligns with ethical considerations and regulatory requirements, fostering the adoption of non-animal testing models. Key players in the market, including contract research organizations specializing in genetic toxicology testing, contribute to its dynamic landscape by offering a diverse range of testing services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Toxicology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Toxicology Testing Market Segmental Analysis

The global genetic toxicology testing market is segmented on the basis of Type, Product, Application and region. By Type, the market is segmented into In Vitro, In Vivo. By Product, the market is segmented into Reagents & Consumables, Assays, Services. By Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry, Other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Genetic Toxicology Testing Market

The increasing recognition among individuals and healthcare professionals regarding the significance of genetic health and its consequences serves as a major catalyst. Genetic toxicology testing plays a crucial role in pinpointing potential hazards linked to exposure to diverse environmental elements like chemicals, medications, and pollutants. This, in turn, contributes to personalized healthcare and facilitates the implementation of preventive measures.

Restraints in the Global Genetic Toxicology Testing Market

Genetic toxicology testing delves into scrutinizing an individual's genetic data, giving rise to ethical considerations regarding privacy, consent, and the potential for data misuse. The meticulous management of genetic information, encompassing its collection, storage, and utilization, necessitates adherence to stringent privacy regulations. This cautious approach may pose a challenge to the broad acceptance and integration of genetic testing practices.

Market Trends of the Global Genetic Toxicology Testing Market

The market is undergoing a notable transition towards in vitro genetic toxicology testing techniques, supplanting traditional animal-based methods with cell-based assays. This shift is fueled by the benefits these assays provide, including diminished ethical concerns, quicker results, cost-effectiveness, and enhanced relevance to human biology. In vitro approaches like the Ames test, micronucleus assay, and Comet assay are increasingly popular for their capacity to furnish precise data on the genotoxicity and mutagenicity potential of substances. Regulatory bodies are actively endorsing the adoption of in vitro methods, amplifying their incorporation into the industry.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Genetic Toxicology Testing Market by Product

  • Market Overview
  • Reagents & Consumables
  • Assays
  • Services

Global Genetic Toxicology Testing Market by Application

  • Market Overview
  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Other

Global Genetic Toxicology Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Covance Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings (LabCorp) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toxikon Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genetic Toxicology Association (GTA) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioReliance Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intertek Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Medicilon Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MPI Research (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Systems Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CeeTox Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gentronix Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabGenius Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Toxicology Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ricerca Biosciences LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ATCC (American Type Culture Collection) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coy Laboratory Products Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Bioarray (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제